Arrhythmias & electrophysiology

The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study

Am Heart JPublished Prospective registry study

Authors' conclusion

RECALL represents the largest prospective registry of patients with AF in Latin America. Our findings highlight important gaps in treatment

Study context

Population
Patients with Atrial Fibrillation (AF) in Brazil, April 2012 to August 2019
Participants
4,585 patients89 sites
Outcome
Characteristics, treatment patterns and clinical outcomes of patients with AF
Follow-up
1 year
Methodological detailsmulticentre, nationwide, 89 sites, 1-year follow-up
  • Multicentre
  • Nationwide
  • 89 sites
  • 1-year follow-up

Main finding

As reported in the abstract

Clinical outcomes (rates/100 patient-years)
Death, rate/100 patient-years
5.76 (5.12-6.47)
Hospitalization due to AF, rate/100 patient-years
15.8 (14.6-17.0)
AF ablation, rate/100 patient-years
5.0 (4.4-5.7)
Cardioversion, rate/100 patient-years
1.8 (1.4-2.2)
Stroke, rate/100 patient-years
2.77 (2.32-3.32)
Systemic embolism, rate/100 patient-years
1.01 (0.75-1.36)

Observational data: associations, not effects.

Further findings

Baseline characteristics

Median age (years)
70 (61, 78)
Women
46%
Permanent AF
53.8%
Previous AF ablation
4.4%
Previous cardioversion
25.2%
Mean (SD) CHA2DS2-VASc score
3.2 (1.6)
Median HAS-BLED score
2 (2, 3)

Anticoagulation at baseline

Not on anticoagulants
22%
VKA, among anticoagulated
62.6%
DOAC, among anticoagulated
37.4%
Reason for no OAC: physician judgment
24.6%
Reason for no OAC: difficulty controlling INR
14.7%
Reason for no OAC: difficulty performing INR
9.9%

Anticoagulation during follow-up

Mean (SD) TTR for the study period
49.5% (27.5)
Anticoagulant use
87.1%
INR in therapeutic range
59.1%

Predictors of mortality (multivariable)

Older age, permanent AF, NYHA class III/IV, CKD, PAD, stroke, COPD and dementia independently associated with increased mortality
Anticoagulant use associated with lower risk of death

Safety

Major bleeding, rate/100 patient-years · 1 year

Major bleeding
2.21 (1.81-2.70)

Original publication

The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study. Am Heart J. Published 15 June 2023. doi:10.1016/j.ahj.2023.06.007

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.